Yali He

1.4k total citations
33 papers, 1.2k citations indexed

About

Yali He is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Yali He has authored 33 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 14 papers in Endocrinology, Diabetes and Metabolism and 14 papers in Genetics. Recurrent topics in Yali He's work include Estrogen and related hormone effects (14 papers), Prostate Cancer Treatment and Research (12 papers) and Hormonal and reproductive studies (10 papers). Yali He is often cited by papers focused on Estrogen and related hormone effects (14 papers), Prostate Cancer Treatment and Research (12 papers) and Hormonal and reproductive studies (10 papers). Yali He collaborates with scholars based in United States, China and United Kingdom. Yali He's co-authors include Duane D. Miller, James T. Dalton, Dong‐Jin Hwang, Michael L. Mohler, Ramesh Narayanan, Donghua Yin, Craig Marhefka, Casey E. Bohl, Suriyan Ponnusamy and Christopher C. Coss and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Cancer Research.

In The Last Decade

Yali He

33 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yali He United States	18	535	508	427	359	114	33	1.2k
Michael L. Mohler United States	19	419 0.8×	416 0.8×	295 0.7×	269 0.7×	108 0.9×	31	1.1k
Masuo Yamaoka Japan	17	351 0.7×	413 0.8×	651 1.5×	296 0.8×	119 1.0×	24	1.0k
Mark Salvati United States	15	399 0.7×	359 0.7×	403 0.9×	357 1.0×	174 1.5×	48	1.0k
Venkatesh Handratta United States	12	435 0.8×	180 0.4×	364 0.9×	412 1.1×	190 1.7×	14	930
Tadas S. Vasaitis United States	19	525 1.0×	307 0.6×	445 1.0×	384 1.1×	86 0.8×	21	1.1k
Yongmi An United States	12	415 0.8×	327 0.6×	230 0.5×	309 0.9×	63 0.6×	12	826
S. Elaine Barrie United Kingdom	16	564 1.1×	362 0.7×	564 1.3×	265 0.7×	220 1.9×	25	1.3k
René Maltais Canada	20	599 1.1×	349 0.7×	67 0.2×	561 1.6×	72 0.6×	84	1.1k
Joanna M. Day United Kingdom	18	449 0.8×	309 0.6×	50 0.1×	501 1.4×	96 0.8×	27	972
Raynard L. Bateman United States	12	754 1.4×	115 0.2×	102 0.2×	200 0.6×	116 1.0×	15	1.1k

Countries citing papers authored by Yali He

Since Specialization

Citations

This map shows the geographic impact of Yali He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yali He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yali He more than expected).

Fields of papers citing papers by Yali He

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yali He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yali He. The network helps show where Yali He may publish in the future.

Co-authorship network of co-authors of Yali He

This figure shows the co-authorship network connecting the top 25 collaborators of Yali He. A scholar is included among the top collaborators of Yali He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yali He. Yali He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Xiangcheng, et al.. (2024). Study on the Mechanism of FOXA2 Activation on Glutathione Metabolic Reprogramming Mediated by ETV4 Transcription to Facilitate Colorectal Cancer Malignant Progression. Biochemical Genetics. 63(5). 4179–4199. 2 indexed citations

He, Yali, et al.. (2024). TFAP2C/FLT3 axis reduces ferroptosis in breast cancer cells by inhibiting mitochondrial autophagy. The International Journal of Biochemistry & Cell Biology. 177. 106691–106691. 1 indexed citations

Yang, Chuanhe, Yali He, Yinan Wang, et al.. (2023). Next‐generation bromodomain inhibitors of the SWI/SNF complex enhance DNA damage and cell death in glioblastoma. Journal of Cellular and Molecular Medicine. 27(18). 2770–2781. 7 indexed citations

He, Yali, Chuanhe Yang, Yinan Wang, et al.. (2021). Novel structural-related analogs of PFI-3 (SRAPs) that target the BRG1 catalytic subunit of the SWI/SNF complex increase the activity of temozolomide in glioblastoma cells. Bioorganic & Medicinal Chemistry. 53. 116533–116533. 9 indexed citations

Ponnusamy, Suriyan, Yali He, Dong‐Jin Hwang, et al.. (2019). Orally Bioavailable Androgen Receptor Degrader, Potential Next-Generation Therapeutic for Enzalutamide-Resistant Prostate Cancer. Clinical Cancer Research. 25(22). 6764–6780. 60 indexed citations

Hwang, Dong‐Jin, Yali He, Suriyan Ponnusamy, et al.. (2018). New Generation of Selective Androgen Receptor Degraders: Our Initial Design, Synthesis, and Biological Evaluation of New Compounds with Enzalutamide-Resistant Prostate Cancer Activity. Journal of Medicinal Chemistry. 62(2). 491–511. 50 indexed citations

Ponnusamy, Suriyan, Christopher C. Coss, Thirumagal Thiyagarajan, et al.. (2017). Novel Selective Agents for the Degradation of Androgen Receptor Variants to Treat Castration-Resistant Prostate Cancer. Cancer Research. 77(22). 6282–6298. 70 indexed citations

Li, Ying, Yiqun Song, Yali He, & Chunyan Zhu. (2016). [Bioavailability in vivo and in vitro transepithelial transport across Caco-2 cell monolayer of pueraria flavonoids bio-adhesive and floating pellets].. PubMed. 51(7). 1144–9. 1 indexed citations

Narayanan, Ramesh, Muralimohan Yepuru, Christopher C. Coss, et al.. (2013). Discovery and Preclinical Characterization of Novel Small Molecule TRK and ROS1 Tyrosine Kinase Inhibitors for the Treatment of Cancer and Inflammation. PLoS ONE. 8(12). e83380–e83380. 20 indexed citations

10.

Kim, Ju‐Hyun, Christopher C. Coss, Christina M. Barrett, et al.. (2012). Role and pharmacologic significance of cytochrome P‐450 2D6 in oxidative metabolism of toremifene and tamoxifen. International Journal of Cancer. 132(6). 1475–1485. 15 indexed citations

11.

Jones, Amanda, Dong‐Jin Hwang, C. B. Duke, et al.. (2010). Nonsteroidal Selective Androgen Receptor Modulators Enhance Female Sexual Motivation. Journal of Pharmacology and Experimental Therapeutics. 334(2). 439–448. 21 indexed citations

12.

Mohler, Michael L., Ramesh Narayanan, Christopher C. Coss, et al.. (2010). Estrogen receptor β selective nonsteroidal estrogens: seeking clinical indications. Expert Opinion on Therapeutic Patents. 20(4). 507–534. 26 indexed citations

13.

Mohler, Michael L., Yali He, Zhongzhi Wu, Dong‐Jin Hwang, & Duane D. Miller. (2008). Recent and emerging anti‐diabetes targets. Medicinal Research Reviews. 29(1). 125–195. 77 indexed citations

14.

Mohler, Michael L., Yali He, Zhongzhi Wu, Seoung‐Soo Hong, & Duane D. Miller. (2007). Non-steroidal glucocorticoid receptor antagonists: the race to replace RU-486 for anti-glucocorticoid therapy. Expert Opinion on Therapeutic Patents. 17(1). 59–81. 14 indexed citations

15.

Mohler, Michael L., Yali He, Zhongzhi Wu, Seoung‐Soo Hong, & Duane D. Miller. (2007). Dissociated non-steroidal glucocorticoids: tuning out untoward effects. Expert Opinion on Therapeutic Patents. 17(1). 37–58. 28 indexed citations

16.

Yin, Donghua, Yali He, Minoli A. Perera, et al.. (2003). Key Structural Features of Nonsteroidal Ligands for Binding and Activation of the Androgen Receptor. Molecular Pharmacology. 63(1). 211–223. 85 indexed citations

17.

Yin, Donghua, Huiping Xu, Yali He, et al.. (2003). Pharmacology, Pharmacokinetics, and Metabolism of Acetothiolutamide, a Novel Nonsteroidal Agonist for the Androgen Receptor. Journal of Pharmacology and Experimental Therapeutics. 304(3). 1323–1333. 37 indexed citations

18.

Yin, Donghua, Wenqing Gao, Jeffrey D. Kearbey, et al.. (2003). Pharmacodynamics of Selective Androgen Receptor Modulators. Journal of Pharmacology and Experimental Therapeutics. 304(3). 1334–1340. 123 indexed citations

19.

He, Yali, Donghua Yin, Minoli A. Perera, et al.. (2002). Novel nonsteroidal ligands with high binding affinity and potent functional activity for the androgen receptor. European Journal of Medicinal Chemistry. 37(8). 619–634. 50 indexed citations

20.

He, Yali, et al.. (2000). ChemInform Abstract: Synthesis and Human β‐Adrenoceptor Activity of 1‐(3,5‐Diiodo‐4‐methoxybenzyl)‐1,2,3,4‐tetrahydroisoquinolin‐6‐ol Derivatives in vitro.. ChemInform. 31(23). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact